Movement Alert｜Xylem Falls 5.18% in After-Hours Trading, Post-downgrade rebound comes under pressure again

Market Focus11-06

On November 6, Xylem fell 5.18% in After-Hours Trading to $99.03 per share, with turnover of $8.7095 million.

The key catalyst in public information was a fresh cautious analyst action: Argus Research downgraded Xylem to Hold from Buy, adding to the wave of more conservative sell-side views that followed the company’s late-October guidance cut.

Background context shows Xylem reported third-quarter adjusted EPS of $1.44 on revenue of $2.20 billion, both slightly below consensus, and lowered full-year adjusted EPS guidance to $5.40-$5.45 from $5.55-$5.70 while forecasting revenue of $8.95 billion versus market expectations of $9.19 billion. Since then, Barclays downgraded the stock to Equalweight with a $104 target, JPMorgan cut it to Underweight with a $90 target, Redburn lowered its target to $129, and Argus has now also turned more cautious, helping explain why the recent repair in the share price lost momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment